论文信息 - The incommensurability of research risks and benefits: practical help for research ethics committees.

The incommensurability of research risks and benefits: practical help for research ethics committees.

3. Law, PK, Goodwin TG, Fang, Q, et al.: Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplantation 1993; 2:485505. 4. Daar, AS, Fuggle, SV, Fabre, JW, et al.: The detailed distribution of HIA-A, B, C antigens in normal human organs. Transplantation 1984; 38:287-98. 5. Appleyard, ST, Dunn, MJ, Dubowitz, V, Rose, ML: Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, imflammatory myopathy, and other neuromuscular disorders. Lancet 1985; i:361-63. 6. McDouall, RM, Dunn, MJ, Dubowitz, V: Expressions of class I and class II MHC antigens in neuromuscular disease. Journal ofNeurological Science 1989; 89:213-26.

Douglas K. Martin | P. Singer | E. Meslin | N. Kohut

[1] Arthur S Slutsky,et al. Ethics of lung transplantation with live donors , 1991, The Lancet.

[2] T. Beauchamp,et al. Principles of biomedical ethics , 1991 .

[3] James Griffin,et al. Are There Incommensurable Values , 1988 .

[4] R. Wittes,et al. Research Methods in Clinical Oncology , 1988 .

[5] R. Levine,et al. Some ethical considerations in clinical trials. , 1979, Clinical pharmacology and therapeutics.

[6] C. Levine,et al. Building a new consensus: ethical principles and policies for clinical research on HIV/AIDS. , 1991, IRB.

[7] E. Meslin. Protecting human subjects from harm through improved risk judgments. , 1990, IRB.

[8] R. R. Levine. Pharmacology: Drug Actions and Reactions , 1983 .

[9] Robert J. Levine,et al. Ethics and Regulation Of Clinical Research , 1982 .